Showing results (3551-3560 of 13,212) with videos related to

Sort By:
Pageof 1,322
Diabetes Care|March 1, 1988
Effect of fat-free diet on insulin requirements in type I diabetes controlled with artificial beta-cellF L Dunn, P B Carroll
Diabetes Care|February 10, 2021
Comparisons of Polyexposure, Polygenic, and Clinical Risk Scores in Risk Prediction of Type 2 DiabetesYixuan He, Chirag M Lakhani, Danielle Rasooly, et al.
Diabetes Care|February 10, 2021
Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of ConceptGeorgia M Davis, Eileen Faulds, Tara Walker, et al.
Diabetes Care|January 23, 2021
Social Deprivation and Incident Diabetes-Related Foot Disease in Patients With Type 2 Diabetes: A Population-Based Cohort StudyJenny Riley, Christina Antza, Punith Kempegowda, et al.
Diabetes Care|February 20, 2021
50 Years of Behavioral Science in Diabetes: A 2020 Vision of the FutureMary de Groot
Diabetes Care|February 24, 2021
The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 DiabetesKlara R Klein, Jennifer L R Freeman, Imogene Dunn, et al.
Diabetes Care|March 3, 2021
Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational StudyRobin Kristófi, Johan Bodegard, Anna Norhammar, et al.
Diabetes Care|March 3, 2021
Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58Avivit Cahn, Itamar Raz, Lawrence A Leiter, et al.
Diabetes Care|February 13, 2021
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 DiabetesOlivia J Collyns, Renee A Meier, Zara L Betts, et al.
Diabetes Care|March 12, 2017
Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist DulaglutideMichael A Nauck, Jean-Louis Frossard, Jamie S Barkin, et al.
Pageof 1,322